Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page
- Check2 days agoChange DetectedThe page’s interface/version footer was updated from Revision v3.5.2 to v3.5.3, reflecting a software release rather than any change to the clinical study details.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedAdded site revision note: v3.5.0; removed revision: v3.4.3.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded Revision: v3.4.2; removed the previous funding-status notice (lapse in government funding) and Revision: v3.4.1.SummaryDifference0.4%

- Check80 days agoChange DetectedA banner notice about a lapse in government funding and NIH operations status was added, and the page version updated from 3.4.0 to 3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.